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Abstract 
Objective: Aging is a major risk factor for cardiovascular disease. Assessing 
direct effects of aging on vascular homeostasis is difficult since in humans it occurs in 
the presence of other risk factors. Arterial thrombosis is the critical event in 
cardiovascular diseases; however, it is not known whether aging per se promotes its 
occurrence. Mice represent an interesting system to address this issue since they 
age without spontaneously developing other risk factors. Thus, we assessed the 
effects of aging on arterial thrombus formation by comparing 2 years old and 11 
weeks old C57Bl6 mice.  
Methods and Results: Organ chamber experiments confirmed the advanced 
level of aging of old mice. As previously shown, old mice exhibited endothelial 
dysfunction however arterial thrombosis induced by photochemical injury was 
unchanged. Arterial tissue factor expression and activity, expression of tissue factor 
pathway inhibitor, thrombomodulin, and plasminogen activator inhibitor 1 as well as 
prothrombin time, partial thromboplastin time, thrombin-antithrombin complex and 
platelet activation were comparable in both groups.  
Conclusions: Although these results cannot be directly extrapolated to 
humans, this study contributes novel important information on the direct effect of 
aging on arterial thrombosis and underscores the importance of controlling modifiable 
risk factors in aged individuals. 
 
Key words: aging; endothelial function; atherosclerosis; cardiovascular risk 
factor; mouse 
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Condensed Abstract 
Aging is a major risk factor for cardiovascular disease however its direct effect 
on acute arterial thrombosis is not known. Despite aging-dependent vascular 
dysfunction, thrombotic responses remain unchanged irrespective of the age. 
Although carried out on mice, this study sheds light of the pathogenesis of aging-
induced cardiovascular disease. 
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Introduction 
The percentage of elderly people in our society is steadily increasing and age 
is considered a major risk factor for the development of cardiovascular disease1. As 
most cardiovascular events such as myocardial infarction and ischemic stroke are 
caused by arterial thrombosis, it is tempting to speculate that advanced age 
promotes the development of arterial thrombosis. Yet, the direct effects of aging on 
arterial thrombosis have not been studied since aging in humans always occurs in 
parallel to other risk factors or atherosclerosis. 
Unlike aged humans, old mice fed a regular diet do not spontaneously develop 
cardiovascular risk factors. Previous work showed that aged mice develop nitric 
oxide (NO) dependent endothelial dysfunction, but do not develop atherosclerotic 
lesions, diabetes or hypertension2-5. Therefore, mice represent an interesting system 
to study the process of aging in isolation and to investigate its direct effects on 
vascular homeostasis.  
In light of the above, we compared 2 C57Bl6 male mice groups, bred and 
housed in same conditions, aged 2 years (old) and 11 weeks (young) and 
investigated age-induced changes in arterial thrombosis in the carotid artery. To this 
end, we employed an established photochemical injury model which principally 
affects the intimal layer as demonstrated by transmission electron microscopy (TEM) 
sections (data not shown) and mimics endothelial injury as occurring in 
atherothrombotic human complications6, 7. Endothelial function was assessed to 
document the stage of vascular aging. It was however not our intention to establish a 
causal link between NO-mediated endothelial dysfunction and age-related changes 
in thrombosis. In fact, this hypothesis had already been addressed by a previous 
study showing that mice lacking endothelial NO synthase (eNOS) exhibit no changes 
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in arterial thrombosis8. In light of the previous work linking inflammation and 
thrombosis9 as well as inflammation an aging10, the inflammatory state of young and 
old mice was assessed by immunhistochemistry and real time PCR. 
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Materials and Methods 
Mice 
Male C57BL/6 mice of the following age groups were examined: a) young 
group: 11 weeks, b) intermediate group: 62 weeks, and c) old group: 105 weeks. All 
mice were bred and housed in a specific pathogen free (SPF) animal facility with 
conventional light cycle at the Institute of Laboratory Animal Science, University of 
Zurich. All experiments were approved by the local authorities.  
 
Organ chamber 
Thoracic aorta was dissected free, excised, and immediately placed into ice-
cold Krebs-Ringer bicarbonate solution. Vessels were cut into 3 mm rings and 
suspended in organ chambers for isometric tension recording (System 700 MO, 
Danish Myo Technology A/S, Aarhus, Denmark) containing 6 mL of Krebs solution 
(37°C, pH 7.4) aerated with 95% O2/5% CO211. After a 30 min equilibration period, 
rings were progressively stretched to the optimal point of their length-tension curve, 
and the presence of a functional endothelium was tested in norepinephrine 
precontracted rings by adding 10–7 mol/L acetylcholine. Endothelial function was 
assessed in norepinephrine precontracted rings by studying the relaxation to 
acetylcholine (10-9 to 10-4 mol/L; Sigma–Aldrich) in the presence or absence of L-
NAME (3×10-4 mol/L; 30 min incubation, Sigma–Aldrich). The NO donor sodium 
nitroprusside (10-9 to 10-4 mol/L; Sigma–Aldrich) was applied to test endothelium-
independent relaxations. Concentration-dependent contractions were established by 
norepinephrine (10-9 to 10-4 mol/L; Sigma–Aldrich).  
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Arterial thrombosis  
Mice were anesthetized with pentobarbital (87 mg/kg i.p.). Rose bengal 
(Fisher Scientific, Fair Lawn, NJ) was injected into the tail vein in a volume of 0.12 mL 
at a concentration of 50 mg/kg body weight. Mice were placed under a dissecting 
microscope and the right common carotid artery was exposed following a midline 
cervical incision. A Doppler flow probe (Model 0.5 VB, Transonic Systems, Ithaca, 
NY) was applied and connected to a flowmeter (Transonic, Model T106) supplying a 
data acquisition system (PowerLab 4/30, AD Instruments). A 1.5-mW green light 
laser (540 nm) (Melles Griot, Carlsbad, CA) was directed at the desired site of injury 
at a distance of 6 cm for 60 minutes or until complete occlusion. Flow was monitored 
for 120 minutes from the onset of injury. Occlusion was defined as flow ≤0.1 mL/min 
for at least 1 minute7. Data were analyzed with ChartPro Software (AD Instruments). 
The photochemical injury protocol leads to an endothelial-specific injury largely 
confined to the diameter of the laser beam which reacts with the laser-sensitive rose 
bengal. As a result of the photochemical injury, endothelial and subendothelial 
procoagulant factors come in contact with circulating coagulation factors resulting in 
the formation of an arterial thrombus. Kinetics of and time to occlusion are monitored 
in real-time with a Doppler probe. 
 
Tissue factor activity  
Carotid arteries were homogenized in 50 µl of lysis buffer (50 mM Tris-HCl, 
100 mM NaCl, 0.1% Triton-X 100, pH 7.4) by manual grinding on ice. Samples were 
then centrifuged at 14000 rpm for 15 min at 4°C and the supernatant was transferred 
to a fresh tube. Tissue factor (TF) activity was assessed with a colorimetric assay 
(Actichrome TF, American Diagnostica); incubation at 37°C allowed TF to form a 
complex with FVII and this complex to cleave FX to FXa. Absorbance was 
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determined at 405 nm and compared to a standard curve generated using known 
amounts of lyophilized TF. 
 
Coagulation pathways 
Plasma from citrated blood (3.2% citrate 1/10) was extracted by 15 minutes 
centrifugation (2500g, 4°C) and stored immediately at -80°C until analysis. 
Prothrombin time (PT) and partial thromboplastin time (aPTT) were assessed by the 
Start4 analyzer (Diagnostica Stago, France), using the according reagents (Roche 
Diagnostics, Switzerland). Thrombin-antithrombin (TAT) complex was measured by 
sandwich ELISA (Enzyme Research Laboratories, USA). 
 
Shear stress-dependent platelet function 
Shear stress-dependent platelet function was assessed with a cone and 
platelet analyzer. Citrated whole blood (200 µL) was circulated in polystyrene wells at 
a shear rate of 1875 s–1 for 2 minutes with a rotating polytetrafluoroethylene cone as 
described12-14. Wells were washed, stained with May-Grünwald dye, and analyzed 
with a microscope connected to an image analysis system (ImageJ). Results are 
expressed as the percentage of surface covered by platelets. 
 
Real-time PCR 
Aortic arches were snap frozen in liquid nitrogen and stored at -80°C until use. 
Total RNA was isolated using TRIzol reagent (Invitrogen). cDNA was generated 
using Ready-To-Go You-Prime First-Strand Beads (Amersham Bioscience) and first-
strand cDNA primer pd(N)6. Real-time PCR was performed using SybrGreen Jump 
start kit (Sigma). Murine primers were as follows: tissue factor (TF): forward (5'-3') 
CAATGAATTCTCGATTGATGTGG, reverse: (5'-3') 
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GGAGGATGATAAAGATGGTGGC; tissue factor pathway inhibitor (TFPI): forward 
(5'-3') ACTGTGTGTCTGTTGCTTAGCC, reverse: (5'-3') 
GTTCTCGTTCCCTTCACATCCC; plasminogen activator inhibitor (PAI-1): forward 
(5'-3') ATCAATGACTGGGTGGAAAGGC, reverse: (5'-3') 
GTTGAACTTGTTGCTCTGAGCCthrombomodulin (TM): forward (5'-3') 
TTTCTTTCTGGGTGTGCTGGC, reverse: (5'-3') TGCTCTGGCTCAGCAGAAGG; 
matrix metalloproteinase 9 (MMP-9): forward (5'-3') 
CCTGGAACTCACACGACATCTTC, reverse: (5'-3') TGGAAACTCACACGCCAGAA;  
eNOS: forward (5'-3') ATTAAATACGCAACAAATAGAGGC, reverse: (5'-3') 
CTCAGTGATCTCCACGTTGGC. Data were normalized to murine S12: forward (5’-
3’) GAAGCTGCCAAAGCCTTAGA, reverse (5’-3’) AACTGCAACCAAAACCCTTC. 
The amplification program consisted of 1 cycle at 95˚C for 10 min, followed by 40 
cycles with a denaturing phase at 95˚C for 30 s, an annealing phase of 1 min at 60˚C 
and an elongation phase at 72˚C for 1 min. For verification of the correct 
amplification, PCR products were analyzed on an ethidium bromide stained 1,5% 
agarose gel. Quantification was performed using 2-ΔΔCt method. 
 
Blood glucose, total cholesterol, plasma triglycerides 
All measurements were performed in the morning after a 14 hours fasting 
period. Glucose was measured in whole blood with ACCU-CHEK aviva system 
(Roche). Cholesterol and triglycerides were determined in heparinized plasma 
(15 minutes centrifugation, 2500g, 4°C) by the enzymatic CHOD-PAP and GPO-PAP 
method (both from Roche), respectively. 
 
Immunohistochemistry 
Aortic roots and carotid arteries were mounted in O.C.T. (Tissue-Tek). 
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Specimens were cut into 8 mm sections, fixed with 4% paraformaldehyde. Sections 
were stained with Oil Red-O (ORO) for 1 hour at room temperature. For the 
assessment of myeloperoxidase (MPO; Labvision), CD68 (Serotec), and tumor 
necrosis factor a (TNF-α; Abcam) sections were fixed in acetone, blocked with 1% 
FCS, and incubated with specific primary antibody. Primary antibodies were revealed 
by goat anti-species specific immunoglobulin antibodies, followed by alkaline 
phosphatase-labelled donkey anti-goat antibodies. Alkaline phosphatase was 
visualized using naphtol AS-BI phosphate and new fuchsin as substrate. Sections 
were counterstained with hemalaun and coverslipped 
 
Statistics 
Data are represented as mean±SEM. Statistical analysis was performed by 2-
tailed unpaired Student t test or ANOVA as appropriate. A probability value of <0.05 
was considered significant. 
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Results 
Vascular tone 
Endothelium-dependent relaxation to acetylcholine was impaired in old as 
compared to young mice (maximal relaxation: -58.9±9.6% vs. -88.0±4.4%, p<0.01; -
log ED50: 6.52±0.27 vs. 7.05±0.09, p=n.s.; n=5; Figure 1A). The nitric oxide synthase 
inhibitor L-NAME abrogated acetylcholine induced relaxation in both groups (maximal 
response: 8.6±5.2% vs. 0.08±3.5%; p=n.s.; n=5; Figure 1A). In contrast, 
endothelium-independent relaxation to sodium nitroprusside was similar in old and 
young mice (maximal relaxation: -93.3±6.8% vs. -111.9±7.4%, p=n.s.; -log ED50: 
7.89±0.21 vs. 7.69±0.17, p=n.s.; n=5; Figure 1B). No difference was observed in the 
contraction to KCl (0.79±0.07 g vs. 0.71±0.07 g; p=n.s.; n=10; Figure 1C), L-NAME 
(11.1±10.9% vs. 10.4±13.2%; p=n.s.; n=5; Figure 1D), or norepinephrine 
(118.7±16.3% vs. 138.9±13.8%; p=n.s.; n=5; Figure 1E). Levels of eNOS mRNA 
expression were comparable in young and old mice (p=0.0739; n=5; data not 
shown). 
 
Arterial thrombosis  
Age-related changes in arterial thrombosis were examined by a carotid artery 
photochemical injury model and assessed by real time blood flow measurement. 
Both time to thrombotic occlusion and the kinetics of thrombus formation were 
unaltered in old (45.5±3.7 min; n=5) as compared to middle aged (53.0±5.8 min; 
p=n.s.; n=6;) or young mice (45.6±5.9 min; p=n.s.; n=5; Figures 2A and 2B). Carotid 
artery blood flow before initiation of photochemical injury was similar in old and young 
mice (0.81±0.07 vs. 0.77±0.07 mL/min; p=n.s.; n=5). 
To improve our understanding of the laser-induced damage to the arterial wall, we 
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examined sections of non-injured and injured carotid arteries by electron microscopy. 
Both the internal elastic membrane and the vascular media remained morphologically 
intact after the laser injury under our experimental conditions indicating that the injury 
is largely confined to the endothelial layer (data not shown).  
 
Analysis of coagulatory and fibrinolytic factors and platelets 
TF activity in carotid artery did not differ between old and young mice (OD405: 
0.68±0.01 vs. 0.5±0.05; p=n.s.; n=5; Figure 3A). In line with this, TF mRNA levels 
(ΔΔCt: 3.7±1.1 vs. 4.8±1.5; p=n.s.; n=5; Figure 3A) as well as levels of its antagonist 
TFPI (ΔΔCt: 0.0134±0.0028 vs. 0.0120±0.0017; p=n.s.; n=5; Figure 3B) were 
comparable in old and young mice. PAI-1 (ΔΔCt: 0.210±0.049 vs. 0.408±0.088; 
p=0.0862; n=5; Figure 3B) as well as TM expression (ΔΔCt: 0.342±0.087 vs. 
0.434±0.153; p=n.s.; n=5; Figure 3B) were not different between the two groups. 
Extrinsic and intrinsic coagulation pathways were examined by measuring PT and 
aPTT, respectively. No changes were observed between old and young mice neither 
for PT (10.7±0.23 vs. 10.9±0.25 s; p=n.s.; n=5; Figure 3C) nor aPTT (26.7±2.8 vs. 
26.2±1.5 s; p=n.s.; n=5; Figure 3C). TAT complex was assayed in plasma and no 
difference was found between young and old mice (4.79±0.16 vs. 4.47±0.093 ng/mL; 
p=0.1236; N=5; data not shown). Platelet function was assessed by determining 
shear stress-dependent platelet adhesion. Old and young mice exhibited similar 
values (5.7±2.0% vs. 4.1±1.5%; p=n.s.; n=5; Figure 3D). 
 
Arterial morphology 
Aortic roots, descending aortae, and carotid arteries were stained by HE and 
Oil-Red-O. Histological features of the arteries were comparable in old and young 
mice (Figure 4). No lipid deposits or fatty streaks were detected in either group. In the 
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aortic root, sporadic single subendothelial cells stained positive for Oil-Red-O in old, 
but not in young mice (Figure 4B). 
 
Blood glucose, plasma cholesterol, and plasma triglycerides 
Fasting blood glucose (81.1±8.3 vs. 60.8±1.3 mg/dL; p=n.s) and total plasma 
cholesterol (81.2±2.2 vs. 59.3±20.3 mg/dL; p=n.s) did not differ in old and young 
mice. Plasma triglyceride levels after 14 hours of fasting were significantly lower in 
old mice as compared to young controls (35.6±7.9 vs. 99.8±4.2 mg/dL; p<0.001). 
 
MMP-9 expression and immunohistochemical analysis of inflammation 
Levels of MMP-9 mRNA expression were comparable in both groups. (ΔΔCt: 
0.00023±0.00004 vs. 0.00026±0.00006; p=n.s.; n=5, Figure 5). Immunohistochemical 
analysis of carotid arteries revealed comparable expression levels of the 
inflammatory markers MPO, CD68, and TNF-α in young and old mice indicating a 
similar and very low level of inflammation in both groups (Figure 5). 
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Discussion 
Increasing age is considered a major risk factor for the development of 
cardiovascular disease1. Thus, studying its molecular mechanisms is an important 
scientific goal especially in view of the growing percentage of elderly people in our 
society. This study demonstrates that aging per se does not promote arterial 
thrombosis. Endothelial function was assessed in order to document the advanced 
stage of vascular aging of old mice but not to establish a direct link between NO-
mediated endothelial function and thrombosis. This link had indeed been investigated 
in a previous study were deletion of eNOS gene was shown not to affect arterial 
thrombus formation8. Old mice indeed exhibited impaired endothelium-dependent 
relaxation, while maintaining an unaltered thrombotic potential. Moreover, the kinetics 
of thrombus formation, arterial TF activity, plasma coagulation times, and platelet 
adhesion as well as modulators of coagulation (TFPI, PAI-1, TM) remained 
unchanged as compared to young controls. Although levels of PAI-1 and eNOS were 
not statistically different, a trend was visible and we cannot fully exclude that a higher 
number of animals might have yielded a different result.  Mice have a life expectancy 
of roughly two years; and the aged mice used in this study were over one hundred 
and four weeks old; thus, their age corresponded roughly to seventy/eighty years of 
age for a human. 
Mice fed a regular diet do not exhibit elevated blood pressure, glucose, or 
cholesterol with age15. Indeed, not only remained fasting blood glucose and plasma 
cholesterol levels unaltered in old mice, fasting triglyceride levels were even 
decreased in these animals; hence, in line with previous studies3, old mice fed their 
entire lifespan a normocaloric diet did not exhibit glucose, cholesterol, or triglyceride 
levels known to be associated with vascular disease. Consistent with these 
observations, histological analysis did not reveal atherosclerotic lesions such as fatty 
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streaks in aortic roots, carotid arteries, or descending aortas of old mice. Sporadic 
single cells stained positive for Oil Red-O in the aortic root, one of the typical sites of 
atherogenesis in mice16, most likely representing intracellular lipids; nevertheless, 
accumulation of inflammatory cells or extracellular lipids were not noted. Vascular 
inflammation, assessed by immuohistochemical staining for the inflammatory marker 
MPO, macrophage marker CD68, and the inflammatory cytokine TNF-α as well as 
expression of MMP-9 was very low in both groups.  
Rupture of atherosclerotic plaques and consequent thrombus formation is the 
main cause of acute cardiovascular events in humans. A very important question in 
this context is whether the increasing incidence of thrombosis with aging solely 
depends on more severe atherosclerosis or whether aging promotes thrombosis by 
itself. In light of these considerations, the absence of atherosclerosis in our mouse 
model is a prerequisite for this study. Hence, we were especially interested in 
studying aging-related changes in the absence of atherosclerosis in order to dissect 
these two parameters. In light of the above and despite the obvious differences to 
humans, mice represent an interesting model for the independent assessment of 
aging on vascular function or, like in the present study, for investigating the direct 
effect of aging on arterial thrombus formation.  
Following the photochemical injury protocol, old mice displayed unaltered time 
to thrombotic occlusion compared to young ones. Furthermore, the kinetics of arterial 
thrombus formation, as assessed by measuring real time blood flow following 
photochemical injury, was comparable. Both the internal elastic membrane and the 
vascular media remained morphologically intact after the laser injury under our 
experimental conditions, as confirmed by TEM (data not shown). Altogether, the 
model has many similarities with an endothelial erosion, which is a well known entity 
triggering an occlusive arterial thrombosis in humans. Hence, these data provide 
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convincing evidence that aging per se does not affect arterial thrombosis in the 
mouse in the absence of additional cardiovascular risk factors or atherosclerosis. 
Age-related endothelial dysfunction occurs in both human17 and murine3 
arteries and is characterized by a decreased bioavailability of NO2, 18, 19. Since aging 
and other risk factors20 occur together in humans, their independent assessment is 
extremely difficult. The old mice examined in this study, exhibited a markedly 
dysfunctional endothelium but no additional risk factor or atherosclerosis; moreover, 
the decreased endothelium-dependent relaxation in old mice underscores a relevant 
impairment of vascular function, providing appropriate conditions to study the impact 
of age-related vascular alterations on arterial thrombosis. These alterations are 
restricted to the endothelium, since endothelium-independent relaxations to sodium 
nitroprusside as well as contractions to both receptor-dependent and -independent 
agonists remained unaltered. Moreover, the observed alterations are solely 
functional, since histological analysis of the arteries did not reveal any structural 
difference between old and young mice. Furthermore, levels of eNOS mRNA 
expression were comparable as also shown in a previous study3. Furthermore, 
genetic deletion of eNOS does not influence arterial thrombus formation8. In line with 
this, despite endothelial dysfunction in the old mice, arterial thrombosis in these 
animals remained unaltered as compared to young controls, indicating that aging per 
se does not directly affect arterial thrombosis.  
In both humans and mice, age-related changes of coagulation factors have 
been reported. Factor VIII, factor VII, and fibrinogen plasma levels increase with age 
in humans21-23 and mice23. In the former, some of these alterations are associated 
with coronary artery disease or overall mortality, although no causal relationship has 
been established24. Such prothrombotic alterations may well be counterbalanced in 
humans by increased plasma levels of anticoagulant proteins like TFPI or protein C, 
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which have been reported as well25. Moreover, such changes may occur secondary 
to activation of coagulation by endothelial damage or endothelial erosion26 rather 
than playing a direct role in thrombosis. In addition, many of these parameters are 
acute phase reactants and may simply represent an enhanced inflammatory 
burden27. Hence, the clinical relevance of such changes in plasma coagulation 
factors with aging is questionable. Consistent with this interpretation, studies in 
centenarians revealed that these individuals exhibit higher levels of procoagulant 
factors than old controls, suggesting that such changes correlate with health and 
longevity and do not necessarily lead to a higher risk for arterial thrombosis. In 
addition, mRNA expression and protein activity of TF, the main trigger of 
coagulation28, and expression of its antagonist TFPI as well as PAI-1 and TM were 
not altered in these animals. PT, aPTT and TAT complex are globally accepted 
parameters for assessing changes in coagulation29; the integral character of these 
tests renders them well suited for assessing the activity of coagulation pathways. 
Age-related changes of these parameters have not been described30, and clinically 
used reference ranges are not age-dependent31. In line with these observations and 
with the reported similar kinetics of arterial thrombosis in vivo, PT, aPTT and TAT 
complex remained unchanged in old mice. Therefore, no functionally relevant 
alteration of the coagulation system was apparent. Additionally, given the unchanged 
thrombotic potential and unchanged PAI-1 levels observed in young and old mice it is 
conceivable to expect that also activation of the fibrinolytic system did not vary with 
age. 
Platelets are crucially involved in arterial thrombus formation. In aged humans 
– not controlled for classical risk factors – elevated levels of β-thromboglobulin and 
platelet factor 432 as well as a lower aggregation threshold to adenosine diphosphate 
and collagen33 have been reported. In addition, von Willebrand factor expression is 
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known to increase with age and correlate with age related risk factors34 and may in 
these subjects enhance platelet activation in vivo. Furthermore, phospholipid 
composition of platelets differs with age in healthy subjects35, suggesting an age 
related alteration in transmembrane signaling. In the present study, platelet function 
was assessed by shear stress induced adherence. No age-dependent alteration in 
platelet function was recorded in these experiments suggesting comparable platelet 
function among young and old mice, implying that the age-related changes described 
may not be directly influenced by aging but rather by other risk factors. 
In summary, this study shows that aging per se does not affect arterial 
thrombosis in the mouse and that age-dependent vascular dysfunction in the 
absence of additional risk factors does not alter arterial thrombus formation. Although 
limited by the use of mice, this study contributes novel important information 
concerning the direct effect of aging on arterial thrombosis and underscores the 
importance of controlling modifiable risk factors in aged individuals. Studying the 
effect of additional risk factors and/or atherosclerosis in concert with aging on arterial 
thrombosis could certainly represent an interesting future development of this study. 
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Figure legends 
Figure 1 
Isometric tension studies in aortic rings of old (filled symbols) and young (open 
symbols) mice A: Endothelium-dependent relaxations to acetylcholine are impaired 
in old as compared to young mice (*p<0.01; **p<0.001; n=5). Pretreatment with L-
NAME abrogates relaxations in both groups (p=n.s. for old vs. young mice; p<0.001 
for control vs. L-NAME; n=5). B: Endothelium-independent relaxations to sodium 
nitroprusside do not differ between old and young mice (p=n.s.; n=5). C: Contractions 
to KCl (80 mM) are similar in old and young mice (p=n.s.; w=weeks; n=5). D: 
Contractions to L-NAME (3x10-4 mol/L) are similar in old and young mice (p=n.s.; 




Aging does not affect arterial thrombus formation A: Old and young mice exhibit 
similar time to thrombotic occlusion (p=n.s.; n=5). B: Real time blood flow plot 
analysis reveals no difference in the flow pattern over time (representative records). 
 
Figure 3 
TF expression and activity, expression of TFPI, PAI-1, and TM, coagulation times, 
and platelet adhesion in old and young mice A: Old and young mice exhibit 
comparable arterial TF activity and TF mRNA (p=n.s.; n=5). B: No significant 
difference in mRNA expression of TFPI, PAI-1 and TM was observed. C: 
Prothrombin time (PT) and partial thromboplastin time (aPTT) do not differ in old and 
young mice (p=n.s.; n=5). D: Shear-stress dependent platelet adhesion is similar in 
old and young mice (p=n.s.; n=5). 
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Figure 4 
Similar arterial histology in old and young mice A: No structural difference is evident 
in aortic roots of old and young mice (HE stain). B: No lipid deposits are detected in 
aortic roots of old and young mice, while sporadic single subendothelial Oil-red-O 
positive cells are detectable in old mice. Descending aorta (C) and carotid arteries 
(D) exhibit similar histology in old and young mice. 
 
Figure 5 
Expression of inflammatory markers MPO, CD-68, and TNF-α in the arterial wall A: 
Expression of the neutrophil marker MPO was comparable in old and young mice. B: 
Macrophage marker CD68 was expressed to a similar extent in both groups. C: The 
pro-inflammatory cytokine TNF-α exhibited a similar expression pattern in old and 
young mice. D: mRNA levels of MMP-9, assessed by real time PCR analysis, were 
comparable in both groups. 
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